2005;293:2865 72. 95. Gierlotka M, Gasior M, Wilczek K, et al. Reperfusion by primary per- cutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). Am J Car- diol. 2011;107:501 8. 96. Rathore SS, Curtis JP, Chen J, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocar- dial infarction: national cohort study. BMJ. 2009;338:b1807. 97. Terkelsen CJ, Jensen LO, Tilsted H-H, et al. Health care system de- lay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data. Ann Intern Med. 2011;155:361 7. 98. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treat- ment and mortality in primary angioplasty for acute myocardial infarc- tion: every minute of delay counts. Circulation. 2004;109:1223 5. 99. Terkelsen CJ, S rensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coro- nary intervention. JAMA. 2010;304:763 71. 100. Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrino- lytic declines as delays increase. Circulation. 2011;124:2512 21. 101. Armstrong PW, Boden WE. Reperfusion paradox in ST-segment eleva- tion myocardial infarction. Ann Intern Med. 2011;155:389 91. 102. Bates ER, Nallamothu BK. Commentary: the role of percutaneous coro- nary intervention in ST-segment-elevation myocardial infarction. Circu- lation. 2008;118:567 73. 103. Ellis SG, Armstrong P, Betriu A, et al. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Am Heart J. 2004;147:E16. 